Anti-mesothelin CAR-T Cells With Advanced Refractory Solid Tumors

Clinical trial NCT04981691 · UNKNOWN

Trial details

NCT number: NCT04981691
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Malignant Solid Neoplasm

Start date: 2021-10-01
Primary completion: 2022-01-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.